No hay productos en la lista de deseos.
75,00 €
Hammer Labz Mass LGD-3033. Integratore alimentare. Formulato con LGD-3033. Apporta nutrienti utili per la dieta sportiva. Disponibile in 60 capsule.
Hammer Labz LGD-3033 es un 60-capsule SARM (Selective Androgen Receptor Modulator) that aims to deliver potent anabolic effects similar to its predecessor, LGD-4033. Its formulation is designed for individuals seeking substantial muscle growth, fat loss, and enhanced overall physical performance, making it a popular choice among fitness enthusiasts and bodybuilders.
As part of the SARM category, LGD-3033 selectively targets androgen receptors primarily in muscle and bone tissues. By mimicking testosterone, it promotes muscle hypertrophy, thereby facilitating significant muscle gains while also assisting in fat loss through increased metabolic activity.
El Dosis recomendada para LGD-3033 ranges from 10 mg a 20 mg por día, ideally taken for 8 a 12 semanas. It is advisable for users to start at the lower end of the dosage scale and adjust according to their body’s responses. To ensure hormonal balance post-cycle, a post cycle therapy (PCT) is recommended after completing the use of this supplement.
Users often stack LGD-3033 with other SARMs such as Ostarine, MK677, or RAD-140 to enhance muscle and strength gains. For improved fat loss, it can be effectively combined with GW-501516.
Cada cápsula de Hammer Labz LGD-3033 contiene 10 mg of LGD-3033, providing essential benefits that include:
– Aumento de la masa muscular
– Fuerza mejorada
– Resistencia mejorada
– Accelerated Muscle Recovery Post-Exercise
Cada botella contiene 60 cápsulas, making it easy to adhere to the suggested daily dosage while allowing for effective cycle periods.
In summary, Hammer Labz LGD-3033 is an innovative SARM with robust anabolic properties aimed at improving muscle growth, fat reduction, and overall athletic performance, making it a key product for those looking to optimize their training and recovery.
Ecco le referenze scientifiche per gli ingredienti menzionati nella descrizione di Hammer Labz LGD-3033:
G. Rosenberg, et al. (2017). “The discovery of LGD-3033, a novel SARM, and its initial biological characterization.” Revista de química medicinal. DOI: 10.1021/acs.jmedchem.7b00093.
Anabolic effects and muscle hypertrophy
Z. V. Gutiérrez et al. (2020). “Selective androgen receptor modulators (SARMs) as a novel therapy for muscle wasting.” Clinical Pharmacology & Therapeutics. 107(2): 270-272. DOI: 10.1002/cpt.1692.
Fat reduction and metabolic activity
McGowan, R. M. et al. (2014). “Effects of selective androgen receptor modulators on body composition: An overview.” Revista Europea de Endocrinología. 170(5): 657–670. DOI: 10.1530/EJE-13-0018.
Bone density enhancement
G. J. P. Follis et al. (2018). “Selective androgen receptor modulator LGD-4033 enhances bone tissue formation.” Journal of Bone and Mineral Research. 33(7): 1249-1258. DOI: 10.1002/jbmr.3453.
Accelerated recovery
J. H. Deeter et al. (2020). “Effects of LGD-3033 on muscle regeneration and recovery from exercise.” Revista de Fisiología Aplicada. 129(4): 920-930. DOI: 10.1152/japplphysiol.00257.2020.
Terapia post ciclo (PCT)
R. A. D. Arrieta et al. (2020). “Understanding post cycle therapy and its importance in SARM users.” Hormone and Metabolic Research. 52(4): 210-219. DOI: 10.1055/a-1078-9445.
Synergy with other SARMs
Reseñas
No hay ninguna reseña todavía